Price
502.35
-0.91%52W Range
Market Cap
₹3,992.28 Cr
Traded: ₹7.14 Cr (0.18%) 0.0x
Free Float: ₹363.30 Cr (1.96% of FF traded)
Volume · 60D trend
1.41 L 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| ROE | -- | -11.0% | -1.0% | -- | -- | Accelerating |
| Return | -- | -- | -- | -- | -- | -- |
| Sales | -- | +34.0% | +32.0% | -- | +23.0% | Decelerating |
| Profit | -- | +27.0% | +32.0% | -- | +109.0% | Accelerating |
Quarterly Results
Jun 2025
Mar 2025
Dec 2024
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|
| Sales | 257 | 191 | 184 | 179 | 180 | 152 | 159 |
| Expenses | 216 | 160 | 159 | 161 | 162 | 125 | 136 |
| Operating Profit | 40 | 31 | 25 | 19 | 18 | 28 | 23 |
| OPM % | 15.7% | 16.4% | 13.6% | 10.4% | 9.9% | 18.1% | 14.4% |
| Other Income | -28 | 32 | 4 | 2 | 1 | -1 | 0 |
| Interest | 1 | 1 | 1 | 2 | 1 | 2 | 2 |
| Depreciation | 20 | 20 | 19 | 19 | 17 | 17 | 13 |
| Profit Before Tax | -9 | 42 | 8 | -0 | 1 | 9 | 9 |
| Tax % | 11.2% | -2.1% | 1.5% | -800.0% | -34.5% | -12.2% | -16.7% |
| Net Profit | -10 | 43 | 8 | 0 | 1 | 10 | 10 |
| Exceptional Items | -- | 25 | 0 | 0 | -- | -3 | -1 |
| EPS (Rs) | -1.2 | 5.5 | 1.0 | 0.0 | 0.1 | 1.3 | 1.4 |
| Sales Growth (YoY) | 42.7% | 25.8% | 15.8% | -- | -- | -- | -- |
| Sales Growth (QoQ) | 34.1% | 4.0% | 2.6% | -0.3% | 18.3% | -4.3% | -- |
| OP Growth (YoY) | 125.9% | 14.1% | 8.8% | -- | -- | -- | -- |
| OP Growth (QoQ) | 28.3% | 25.7% | 33.9% | 4.5% | -35.2% | 19.9% | -- |
| Profit Growth (YoY) | -- | 54.0% | -30.0% | -- | -- | -- | -- |
| EPS Growth (YoY) | -1300.0% | 307.5% | -27.9% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -122.0% | 440.6% | 2425.0% | -60.0% | -92.5% | -4.3% | -- |
| OP Margin | 15.7% | 16.4% | 13.6% | 10.4% | 9.9% | 18.1% | 14.4% |
| Net Margin | -3.7% | 22.7% | 4.3% | 0.2% | 0.4% | 6.5% | 6.5% |
| Material Cost % | -- | -- | -- | -- | -- | -- | -- |
| Employee Cost % | 46.7% | 46.8% | 48.9% | 49.4% | 47.6% | 43.8% | 46.4% |
| P/S | 4.92 | 5.58 | -- | -- | -- | -- | -- |
| P/E | 94.60 | 63.13 | -- | -- | -- | -- | -- |
| P/B | 3.90 | 3.85 | 7.19 | -- | -- | -- | -- |
Exchange Filings
50The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kotak Mahindra Mutual Fund
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Capillary Technologies International Pte Ltd
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Capillary Technologies International Pte Ltd
Announcement under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Transcript - Earnings Call - Financial Results for the quarter ended June 30, 2026.
Financial Results for the quarter ended 30-06-2026
outcome of the Board meeting- Q1 Financial results
Capillary Technologies India Limited has submitted the BRSR with the Exchange.
Capillary Technologies India Limited has submitted 14th Annual Report with the exchange
Capillary Technologies India Limited has informed the exchange regarding 14th AGM of the company to be held on August 28, 2026.
Allotment of Equity Shares under Capillary Employees Stock Option Scheme - 2021
Intimation of schedule of Investors Meeting.
Compliance certificate under Regulation 74 (5) of SEBI (DP) Regulations, 2018 for the quarter ended June 30, 2026
This is to inform that one of the Company''s recently acquired overseas step-down subsidiary has been affected by a cyber-enabled banking fraud.
Revised intimation of granting of stock options under Capillary Employees Stock Option Scheme - 2021
Intimation of grant of stock options
Intimation of Trading Window closure
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mirae Asset Mutual Fund
We wish to inform you that the Company through its representative will be participating in the investor conference.
We wish to inform you that Board of Directors in its meetng held today has approved tp hold the 14th AGM of the Company on Friday, August 28, 2026.
Resignation of Mr. Ravi Jaswani, Head - Finance designated as SMP of the Company
Schedule of Analyst/Institutional Investor Meeting
We hereby inform you the schedule of Analyst meet / Institutional Investor meet on Wednesday, May 20, 2026
We wish to inform you that the Board of Directors of the Company, at its meeting held on May 06, 2026, has appointmed Mrs. Gireddy bhargavi reddy as the Nodal Officer of the Company.
Investor Presentation
Earnings call transcript - Financial Results for the quarter and year ended march 31, 2026
Newspaper Publication - financial results for the quarter and year ended March 31, 2026
Schedule of Analyst meet/Institutional Investor meet.
Outcome of Board Meeting
Reappointment of Internal Auditor
Outcome of Board Meeting held on May 06, 2026.
Press Release - Financial Results for the quarter and year ended March 31, 2026
Investor Presentation of Financial Results for the quarter and year ended March 31, 2026.
Annual secretarial Compliance Report for the FY 2025-26
AUDIO RECORDING OF THE EARNINGS CONFERENCE CALL WITH ANALYST/INVESTORS HELD ON MAY 06, 2026
Monitoring Agency Report for the quarter ended March 31, 2026.
This is in furtherance to the disclosure filed by the Company on February 24, 2026, the Company has completed all closing condition with regard to the acquisition.
We wish to inform you that post announcement of financial results for the quarter and year ended March 31, 2026, the Company will be hosting an earnings conference call with analysts and ....
Capillary Technologies India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/05/2026 ,inter alia, to consider and approve the audited standalone ....
Allotment of Equity Shares under Capillary Employees Stock Option Scheme 2021
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Compliance Certificate Under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended March 31, 2026.
Intimation under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations') - Schedule of Analyst/Institutional ....
Please find enclosed herewith a copy of Press/Media Release titled Capillary Technologies appoints Sumit Kumar as President of the Middle East, Africa and India.
We wish to inform you that NRC of the Company granted 6,563 stock options of the Company of face value of Rs. 2/- each, to the eligible employees of the company under ESOP Plan 2021, vide ....
Intimation of Trading Window Closure.
Intimation of Schedule of Analyst/Institutional Investor Meeting.
Result of Postal ballot and submission of Scrutinizer report
Results of Postal Ballot and submission of Scrutinizer Report.
Allotment of Equity Shares under capillary Employees Stock Option Scheme 2021.
Capillary Technologies India Limited has informed the exchange regarding the Press/Media Release dated March 04, 2026.
Annual Reports
12026
Concalls
2Feb 2026
28 Feb 2026Held by ETFs
1 ETFs hold capillary · sorted by weight
Held by Mutual Funds
22 schemes hold capillary · sorted by weight